21
May 5 th , 2020 QUARTERLY STATEMENT JAN. – MAR. 2020

QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

May 5th, 2020

QUARTERLY STATEMENT JAN. – MAR. 2020

Page 2: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

May 05, 2020 | Quarterly Statement January - March 2020

Page 2

Q1 KEY MESSAGES

COVID-19

SAFETY AND HEALTH OF

EMPLOYEES

CONTINUE TO SERVE CONSUMERS

SUPPORT SOCIETY

CONSUMER

-3.3%SALES GROWTH

Note: Organic sales growth on a like-for-like basis.

TESA

-5.1%SALES GROWTH

-0.6%

NIVEA

+11.5%

DERMA

+10.1%

HEALTHCARE

-35.8%

LA PRAIRIE

Page 3: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

May 05, 2020 | Quarterly Statement January - March 2020

Page 3

BUSINESS IMPACT CORONA

CONSUMER SHOPPER AND CUSTOMER AIR TRAFFIC

• COLLAPSE OF TRAVEL RETAIL

• TOURISM: SUN SEASON

• ON-LINE

• LESS SHOPPING TRIPS

• BIGGER BASKETS

• POSTPONED ACTIVATION

• CLOSED SHOPS

• CATEGORY: PERSONAL CARE

• MEDIA SHIFT

• PREFERS TRUSTED BRANDS

Page 4: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

May 05, 2020 | Quarterly Statement January - March 2020

Page 4

BUSINESS MEASURES CORONA

SUPPLY CHAIN COST INITIATIVES

• IMPACT MITIGATION VIA COST

REDUCTION EFFORTS

• CONTAIN FIXED COST

• BEIERSDORF ‘SOLIDARITY PACT’

• SECURE STABLE SOURCING

• MAINTAIN SERVICE LEVEL

Page 5: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

May 05, 2020 | Quarterly Statement January - March 2020

Page 5

COMPETITIVE SUSTAINABLE GROWTH

OUR COMMITMENT

ACCELERATE DIGITAL CONSUMER CONNECTION

WIN WITH SKIN CARE UNLOCK WHITE SPOT POTENTIAL

BUILD ON STRONG FOUNDATIONS:COMPLIANCE – CORE VALUES – CULTURE – SUSTAINABILITY

FUEL THE GROWTH THROUGH INCREASED PRODUCTIVITY

Page 6: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

CLOSE TO OUR CONSUMERS

Consumer connection

Cater to increased and changing demand

Modify activation & communication

May 05, 2020 | Quarterly Statement January - March 2020

Page 6

Page 7: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

DIGITAL CONSUMER CONNECTION

Page 7

Q1 2020

+23%growth

eCommerce

May 05, 2020 | Quarterly Statement January - March 2020

Q1 2020

+43%growth in online spend

Advertising

Page 8: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

DIGITAL CONSUMER CONNECTION

May 05, 2020 | Quarterly Statement January - March 2020

Page 8

10K

High-quality images

12 MIO.

11Parameters

Women Worldwide

Page 9: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

WIN WITH SKIN CARE

One of the most successful launches ever

May 05, 2020 | Quarterly Statement January - March 2020

Page 9

Biggest contributor to Derma growth

Global leader „even skin“

Extension to the Sun category in 2020

Page 10: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

UNLOCK WHITE SPOTS

Page 10

Successful roll-out to European countries in Q1 2020

Excellent feedback from customers

Additional categories to come

May 05, 2020 | Quarterly Statement January - March 2020

Page 11: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

CORPORATE VENTURE FUND

May 05, 2020 | Quarterly Statement January - March 2020

Page 11

A strong partnership to drive sustainable aerosol

innovations for the industry and Beiersdorf.

Latest investment:

Equity stake in UK-based

Salford Valve Company (Salvalco)

Invest in disruptive technologies &

new business models

Investments in line with

C.A.R.E.+ strategic pillars,

e.g. sustainability focus

Page 12: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

SUPPORT SOCIETY

Page 12

Page 13: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

FINANCIAL RESULTS Q1 2020

Page 14: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

GROUP – SALES RESULTS

May 05, 2020 | Quarterly Statement January - March 2020

Page 14

SALES Q1 2019 SALES Q1 2020 NOMINAL GROWTH ORGANIC GROWTH

€ MILLION € MILLION

CONSUMER 1,598 1,581 -1.0% -3.3%

TESA 349 329 -5.7% -5.1%

GROUP 1,947 1,910 -1.9% -3.6%

Page 15: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

CONSUMER – GROWTH

May 05, 2020 | Quarterly Statement January - March 2020

Page 15

ORGANIC SALES GROWTH IN %

+5.0

+6.8

+4.8

-3.3

Q1 2020FY 2019FY 2018 Q1 2019

*Effect on consumer organic sales growth if sales in Argentina had been calculated at constant FX rates.

+0.9*

+0.6*

+0.6*

+0.3*

Page 16: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

SALES Q1 2019 SALES Q1 2020 NOMINAL GROWTH ORGANIC GROWTH

€ MILLION € MILLION

WESTERN EUROPE 655 596 -9.0% -9.6%

EASTERN EUROPE 149 154 +3.7% +5.4%

EUROPE 804 750 -6.6% -6.8%

CONSUMER – EUROPE

May 05, 2020 | Quarterly Statement January - March 2020

Page 16

• LA PRAIRIE AFFECTED BY THE COLLAPSE OF TRAVEL RETAIL, AND UP TO 85% OF DOORS WERE CLOSED

• LOCKDOWN COUNTRIES ITALY, SPAIN AND FRANCE WITH MAJOR SALES IMPACT

• RESILIENT Q1 PERFORMANCE IN POLAND AND RUSSIA DESPITE A CHALLENGING ENVIRONMENT

Page 17: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

SALES Q1 2019 SALES Q1 2020 NOMINAL GROWTH ORGANIC GROWTH

€ MILLION € MILLION

NORTH AMERICA 123 183 +48.1% +1.3%

LATIN AMERICA 143 154 +7.9% +18.9%

AMERICAS 266 337 +26.5% +10.6%

CONSUMER – AMERICAS

May 05, 2020 | Quarterly Statement January - March 2020

Page 17

• NORTH AMERICAN SALES DRIVEN BY AQUAPHOR AND NIVEA BODY WASH

• IN THE U.S. STRONG GROWTH IN DERMA OFFSETS DECREASE IN LA PRAIRIE

• Q1 SALES IN LATIN AMERICA DRIVEN BY STRONG GROWTH IN BRAZIL

Organic sales growth if sales in Argentina had been calculated at constant FX rates: Latin America +23.0%, Americas +12.7% * Including Coppertone

*

Page 18: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

SALES Q1 2019 SALES Q1 2020 NOMINAL GROWTH ORGANIC GROWTH

€ MILLION € MILLION

AFRICA/ASIA/AUSTRALIA 528 494 -6.4% -5.0%

CONSUMER – AFRICA/ASIA/AUSTRALIA

May 05, 2020 | Quarterly Statement January - March 2020

Page 18

• LA PRAIRIE WITH DOUBLE-DIGIT SALES DECELERATION IN ASIA AND AUSTRALIA

• WEAK DEMAND IN INDIA

• STRONG GROWTH IN MALAYSIA AND PHILIPPINES

Page 19: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

TESA – GROWTH

May 05, 2020 | Quarterly Statement January - March 2020

Page 19

ORGANIC GROWTH Q1 2020

DIRECT INDUSTRIES TRADE MARKETS TESA TOTAL

-8.5% 0.0% -5.1%

AUTOMOTIVE

ELECTRONICS

PRINT AND PAPER

BUILDING SUPPLY

CONSUMER & CRAFTSMEN

GENERAL INDUSTRIAL MARKETS

Page 20: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

May 05, 2020 | Quarterly Statement January - March 2020

Page 20

INSIGHTS 2020

Major shift in consumer and shopping behavior

Impact mitigation through cost initiatives

Reliable supply situation

Currently no visibility beyond a difficult Q2

Strong financial position

Page 21: QUARTERLY STATEMENT JAN. MAR. 2020 - pharmabiz.net · 5/5/2020  · sales q1 2019 sales q1 2020 nominal growth organic growth € million € million western europe 655 596 -9.0%

Q&A

May 05, 2020 | Quarterly Statement January - March 2020

Page 21